• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Late-Life Depression

Late-Life Depression

9780195152746
610.74 zł
549.67 zł Save 61.07 zł Tax included
Lowest price within 30 days before promotion: 549.67 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
We live in an ageing world. Illnesses that are prevalent and cause significant morbidity and mortality in older people will consume an increasing share of health care resources. One such illness is depression. This illness has a particularly devastating impact in the elderly because it is often undiagnosed or inadequately treated. Depression not only has a profound impact on quality of life but it is associated with an increased risk of mortality from suicide and vascular disease.In fact for every medical illness studied, e.g. heart disease, diabetes, cancer, individuals who are depressed have a worse prognosis. Research has illuminated the physiological and behavioural effects of depression that accounts for these poor outcomes. The deleterious relationship between depressionand other illnesses has changed the concept of late-life depression from a psychiatric disorder that is diagnosed and treated by a psychiatrist to a common and serious disorder that is the responsibility of all physicians who care for patients over the age of 60. This is the first volume devoted to the epidemiology, phenomenology, psychobiology, treatment and consequences of late-life depression. Although much has been written about depressive disorders, the focus has been primarily on the illness as experienced in younger adults. The effects of ageing on the brain, the physiological and behavioural consequences of recurrent depression, and the impact of other diseases common in the elderly, make late-life depression a distinct entity. There is acompelling need for a separate research program, specialized treatments, and a book dedicated to this disorder. This book will be invaluable to psychiatrists, gerontologists, clinical psychologists, social workers, students, trainees, and others who care for individuals over the age of 60.
Product Details
OUP USA
85559
9780195152746
9780195152746

Data sheet

Publication date
2004
Issue number
1
Cover
hard cover
Pages count
420
Dimensions (mm)
222 x 286
Weight (g)
1395
  • Introduction; Part 1: Epidemiology and the burden of illness; The epidemiology of depressive disorders in late life; The social and financial burden of late-life depression to society and individuals; Part 2: The phenomenology and differential diagnosis of late-life mood disorders; Unipolar depression; Bipolar disorders; Dysthymic disorder in the elderly; Non-major clinically significant depression in the elderly; Mixed cognitive and depressive syndromes; Suicide; Bereavement and depression; Part 3: The psychobiology of late-life depression; Neuropsychological assessment of late-life depression; Structural and functional brain imaging in late-life depression; Late-life depression and the vascular hypothesis; Hypothalmic-pituitary-adrenal axis activity in mood and cognition in the elderly: Implications for symptoms and outcomes; The neuroendocrinology of ageing; Part 4: Treatment; Pharmacokinetics and pharmacodynamics in late life; Antidepressant medication for the treatment of late-life depression; Antidepressant side effects; Mood stabilizers; Stimulants; Antipsychotics; Electroconvulsive therapy in late-life depression; Pharmacologic treatment of depression in Alzheimers disease; Psychotherapy in old-age depression: progress and challenges; Treatment of depression in residential settings; Part 5: Depression co-morbid with other illnesses; Depression co-morbid with ischemic heart disease; Vascular disease and late-life depression: Stroke; Substance abuse co-morbidity; Basal ganglia disease and depression; Major depressive disorder in Alzheimers disease;
Comments (0)